Schneyer Mark C. bought ACAD
October 15, 2026 · Form 4 insider transaction
Schneyer Mark C. bought 6,815 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 15 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,815
Price
$0.00
Total value
N/A
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 15, 2026
Filing dateOctober 30, 2026
Shares owned after74,643
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at incremental 25% of target. Together with the vesting on August 16, 2024 and September 12, 2025, the performance stock units have vested at 100% of target.